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The main advantage to be obtained by a heterogenous graft is that there will be no donor site with its attendant pain and possible hematoma formation, infection or even fracture. Also, time is saved at operation, large quantities are available and the shape of the graft can be selected for a specific site with ease.
The Kiel Graft In 1952 Maatz of Kiel introduced this heterogenous graft which he claimed was incorporated in suitable conditions into living bone faster than an autograft. Method of preparation: Young calves are the donor source; a young animal is said to be better because it has larger intertrabecular spaces in the marrow cavity which makes for easier substitution. Soft tissue is removed and blood is washed out with water. The bone is treated with 30% hydrogen peroxide at room temperature for up to two days, the temperature never exceeding 35°C; it is then washed with water and acetone, air dried and finally sterilized with ethylene oxide, a gas with a small molecular weight, allowing complete perretration into the porous cavities of the bone.
The final graft material consists only of fibrils and crystallites with a residue of 31 % protein (Maatz & Bauermeister 1957) . This protein residue is of great importance since it is recognized that new bone formation decreases as the protein content of the graft decreases (Fuchs 1966) . Although the catalyst for osteoblastic activity remains unknown, it has been suggested by some workers that a chemical is responsible and that this chemical may be a glycoprotein. Burwell (1966) has rec,ntly suggested, however, that the fresh red marrow from an autogenous graft plays an important part in stimulating osteogenesis.
A popular misconception about Kiel bone is that it is inorganic. It has, however, a large protein content; normal bone has approximately 38 % protein, and Kiel bone 31 %.
Clinical use: Prior to its introduction into clinical use, extensive experimental work was carried out by Maatz & Bauermeister (1957) and others; they showed that the new graft had no antigenic properties and was satisfactorily replaced in animals by a process termed 'creeping substitution'. As a result of these trials, certain stipulations were made for the use of Kiel bone. It is essential that the cancellous bone be left intact to form a climbing framework and to facilitate replacement by the host. Therefore, an adequate bed must be prepared; the grafts must be applied in close apposition both to themselves and to the bed for, as this is a process of creeping substitution, the new bone cannot be expected to bridge a gap. Furthermore, the graft should not be crushed, as this will destroy the trabecular framewotk. Graft material of high mechanical strength, consisting mainly of cortical bone with fewer and smaller intertrabecular spaces, has little capacity for promoting callus. In their experience, onlay proved more successful than inlay grafting (Maatz & Bauermeister 1961) .
The acceptance of the Kiel graft in this country has been slow, the first series being reported by Williams (1966) , who reviewed 14 cases of delayed union of fractures of the tibial shaft in which a Kiel bone onlay graft had been used successfully.
Materialfor Present Review
During the period January 1965 to August 1966, the Kiel bone graft has-been used on 82 occasions in 81 patients being treated at St George's Hospital and Redhill General Hospital. We cannot claim that this trial has been conducted in a scientific manner; indeed, in the early stages our method of use of this new material was often incorrect but we feel that it will be of some value to report our results. Assessment of the results is extremely difficult because they can only bejudged on symptomatic relief and on radiological appearances; the latter can be particularly deceptive. The one certain way would be to explore every graft but we have not felt justified in doing this. Hence we convey clinical impressions rather than state scientific fact. However, we have made an attempt to distinguish between success and failure based on both symptomatic relief and X-ray appearance. In 5 clinically successful cases, radiological incorporation has been slow; we have classified these as successes.
Results: There was a fairly even age distribution of the patients; the failure rate was not affected by age. The follow-up period varied between four months and two years. Table 1 shows the wide range of orthopedic operations in which we have used the graft and the results achieved. Three varieties of the preparation, cortical, cancellous and combined cortico-cancellous bone, were used and the failure rate was fairly equally distributed between the three. In comparing the way the graft was used, the inlay method seemed to have the advantage and it can be seen that the cancellous graft used as an onlay frequently failed (Table 2 .) Analysis offailures: Eighteen cases were classified as failures, 2 being due to factors not related to the grafting: a recurrence in a giant cell tumour and avascular necrosis in a femoral head when Kiel graft had been used to create a shelf in an old congenital dislocation of the hip.
In 11 cases, failure was due to improper use of the graft or a badly planned operation; either too much stress was applied to a cancellous graft leading to crushing or cancellous blocks were loosely applied as onlay grafts. We now consider that these were doomed to failure because the graft bed was inadequate. Five cases remain in whom we think the graft was properly used but failure nevertheless occurred; 2 of them were reexplored. The first was a young man with spondylosis who, after a previously failed autogenous H-graft, was regrafted with cortical and cancellous Kiel graft using strips of cortical bone screwed to the spinous processes and cancellous bone applied to the rawed lamin2e and destroyed joints. This was successful for seven months; when pain recurred, massive new bone formation was found at the re-exploration but there proved to be a hairline interspinous defect.
The second case was a posterior fusion for lumbar spondylosis using a similar method; reexploration at six months showed that the cortical The other 3 failures were a long fusion for scoliosis, a Dwyer's calcaneal osteotomy for talipes equinovarus and a pan-talar arthrodesis for poliomyelitis.
Biopsy of the first failed graft for spondylosis showed good replacement of the graft throughout (Fig 1) . A section of the second failed graft for spondylosis showed poor replacement of the graft and aggregations of plasma cells and lymphocytes, suggesting an immune response by the host (Fig 2) .
Discussioti
From this small series it would appear that, with one possible exception, the graft has not been rejected. Sepsis intervened in 3 cases only but these were all ultimately successful grafts. We have had no experience of using this graft in cases of bone sepsis.
We have found this to be a highly successful material for filling cavities. Inlay grafting has been more successful than onlay, which is the reverse of other reported series but may well be accounted for by incorrect use of cancellous bone as an onlay in the early cases.
In our opinion, one of the main advantages of the Kiel graft is that the intertrabecular spaces are already cleared of soft tissue, which facilitates vascularization of the implant; incorporation should follow provided that the adjacent host tissue has osteogenic potential.
On reviewing the literature, it has been difficult to to find comparative figures for the results of autogenous grafting but the approximate failure rate is around 12%. Our overall failure rate was 22%; this is very high but, if one leaves out the grafts which we now believe were incorrectly used, the failure rate comes down to 10%. In view of the advantages of the Kiel graft, we feel encouraged to continue its use but emphasize that it must be used correctly.
